Navamedic ASA: Q4 2016 results
Oslo, 15 February 2017 - Navamedic ASA (OSE: NAVA), reported revenues of NOK 81.6 million in the fourth quarter of 2016 (NOK 65.4 million in Q4 2015), and an EBITDA of NOK 5.7 million (NOK -0.1 million in Q4 2015). The company expanded distribution of Imdur® to the Netherlands and the Baltic states, following a strong quarter in the Nordic markets. The first Sippi® BLE (low-energy Bluetooth) with wireless communication capabilities was produced in the quarter and commercialisation continues to be on-track. "Navamedic had a strong finish to the year with significant sales growth driven by